{"gene":"KCNJ9","run_date":"2026-06-10T02:59:49","timeline":{"discoveries":[{"year":1999,"finding":"GIRK3 (Kir3.3) co-assembles with GIRK1 to form functional heteromultimeric G-protein-gated inwardly rectifying K+ channels in CHO cells; the GIRK1/GIRK3 channel has nearly identical single-channel conductance, kinetics, and Gβγ sensitivity compared to GIRK1/GIRK2 and GIRK1/GIRK4 channels.","method":"Patch-clamp electrophysiology and CHO cell expression system","journal":"The Journal of membrane biology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro functional reconstitution with single-channel characterization, single lab, single study","pmids":["10341034"],"is_preprint":false},{"year":2000,"finding":"GIRK2 and GIRK3 co-assemble to form functional heteromultimeric GIRK channels in CHO-K1 cells; these GIRK2/GIRK3 channels have approximately 5-fold lower sensitivity to activation by Gβγ compared to GIRK1-containing channels. GIRK2/GIRK3 complexes were immunoprecipitated from transfected cells and purified from native brain tissue.","method":"Patch-clamp electrophysiology, co-immunoprecipitation, co-transfection in CHO-K1 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — functional reconstitution with electrophysiology plus reciprocal co-IP from both transfected cells and native brain tissue, single lab but two orthogonal methods","pmids":["10956667"],"is_preprint":false},{"year":2002,"finding":"G-protein-gated K+ channels containing Kir3.2 (GIRK2) and Kir3.3 (GIRK3) subunits mediate acute opioid ([Met]5enkephalin)-induced hyperpolarization of locus ceruleus neurons; Kir3.2/3.3 double knockout abolished ~80% of the opioid-sensitive current, and residual current was blocked by Ba2+/Cs+. The cAMP-dependent cation conductance does not contribute significantly to acute opioid inhibition.","method":"Brain slice patch-clamp electrophysiology in Kir3.2 KO, Kir3.3 KO, and Kir3.2/3.3 double KO mice","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO with defined cellular phenotype and pharmacological validation, replicated across multiple genotypes","pmids":["12040038"],"is_preprint":false},{"year":2003,"finding":"Kir3.3 (GIRK3) protein is specifically sorted to axons in a population of large GABAergic interneurons in the CA3 region of rodent hippocampus, where it colocalizes with the vesicular GABA transporter in large synaptic terminals; this axonal sorting is distinct from the somatodendritic localization of most Kir3 subunits.","method":"Immunocytochemistry, primary hippocampal subarea cultures, light and electron microscopy","journal":"Molecular and cellular neurosciences","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct localization by immunocytochemistry and EM in primary cultures and brain tissue, single lab, single study","pmids":["14664820"],"is_preprint":false},{"year":2008,"finding":"Kir3.3 (GIRK3) protein is expressed in serotonergic supraependymal axons of dorsal raphe neurons at the light and electron microscopic level, with no other Kir3 subfamily members or KATP subunits detectable in these axons, suggesting a role in excitability autoregulation of these fibers.","method":"Immunocytochemistry (light and electron microscopy)","journal":"Neuroscience letters","confidence":"Low","confidence_rationale":"Tier 3 / Weak — localization by immunocytochemistry alone, no functional consequence established, single lab","pmids":["18755244"],"is_preprint":false},{"year":2008,"finding":"Kcnj9 (GIRK3) knockout mice have attenuated analgesic responses to opioid (morphine), α2-adrenergic (clonidine), and cannabinoid (WIN55,212-2) drugs, placing GIRK3 in the pathway of multi-drug analgesic signaling; differential expression of Kcnj9 in the periaqueductal gray between 129P3 and C57BL/6 strains is driven by cis-acting genetic elements.","method":"QTL mapping in F2 mice, in silico haplotype analysis, Kcnj9 knockout phenotyping with hot-plate analgesia assay","journal":"Pharmacogenetics and genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO with defined phenotypic readout plus QTL/computational mapping, two orthogonal approaches, single lab","pmids":["18300945"],"is_preprint":false},{"year":2009,"finding":"Kcnj9 (GIRK3) null mutant mice exhibit significantly less severe withdrawal from pentobarbital, zolpidem, and ethanol compared to wild-type littermates, demonstrating a role for GIRK3 in sedative-hypnotic withdrawal; reduced Kcnj9 expression is associated with attenuated withdrawal severity.","method":"Generation of Kcnj9-null mice, sedative-hypnotic withdrawal behavioral assays","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with defined behavioral phenotype across multiple drugs, single lab","pmids":["19759313"],"is_preprint":false},{"year":2010,"finding":"GABA-B receptors form stable protein complexes with GIRK channels containing the GIRK1 and GIRK3 subunits (GIRK1/GIRK3 heterotetramers); BRET measurements in living cells showed direct interaction, and co-IP confirmed complexes in HEK-293 cells and in vivo in cerebellar granule cells. These receptor-channel complexes are likely assembled shortly after biosynthesis in the ER/Golgi.","method":"Bioluminescence resonance energy transfer (BRET), co-immunoprecipitation, confocal and electron microscopy in HEK-293 cells and native cerebellar tissue","journal":"The European journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP plus BRET in living cells plus in vivo tissue confirmation, multiple orthogonal methods, single lab","pmids":["20846323"],"is_preprint":false},{"year":2010,"finding":"Kir3.3 (GIRK3) directly binds to NCAM and TrkB via its C-terminal intracellular domain; TrkB co-expression increases Kir3.1/3.3-mediated K+ currents in Xenopus oocytes, while NCAM co-expression reduces this enhancement; TrkB regulates cell surface expression of Kir3.3 (but not Kir3.2), and TrkB-deficient mice have reduced Kir3.3 at the plasma membrane; premature expression of Kir3.1/3.3 in hippocampal neurons reduces NCAM-induced neurite outgrowth.","method":"Co-immunoprecipitation, surface biotinylation, Xenopus oocyte electrophysiology, immunocytochemistry, TrkB-KO mouse analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (Co-IP, surface biotinylation, electrophysiology, KO mice), direct binding sites identified, single lab","pmids":["20610389"],"is_preprint":false},{"year":2015,"finding":"GIRK3 expression in the ventral tegmental area (VTA) gates the mesolimbic dopaminergic pathway response to ethanol; GIRK3 KO mice show blunted ethanol-induced excitation of VTA neurons and reduced dopamine release in the nucleus accumbens; viral re-expression of GIRK3 in VTA rescued the KO phenotype and reduced ethanol binge drinking, demonstrating that VTA GIRK channel subunit composition determines DA neuron sensitivity to ethanol.","method":"GIRK3 KO mice, viral vector-mediated re-expression in VTA, in vivo microdialysis (dopamine), brain slice electrophysiology, voluntary ethanol consumption assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO phenotype with viral rescue, multiple orthogonal readouts (electrophysiology, microdialysis, behavior), single lab but multiple methods","pmids":["25964320"],"is_preprint":false},{"year":2016,"finding":"The GIRK3 subunit is required for methamphetamine-induced attenuation of GABA-B receptor-activated GIRK currents in VTA dopamine neurons; this methamphetamine-dependent plasticity requires both D1R-like and D2R-like receptor activation and is independent of GABA-B R2 subunit dephosphorylation.","method":"Brain slice patch-clamp electrophysiology in GIRK3 KO and wild-type mice, pharmacological receptor antagonism, repeated methamphetamine treatment paradigm","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean KO with defined cellular phenotype, pharmacological dissection of upstream signaling requirements, single lab but multiple orthogonal approaches","pmids":["26985023"],"is_preprint":false},{"year":2022,"finding":"GIRK3 controls endochondral bone formation in non-excitable chondrocytes; Girk3-/- mice have longer femurs and tibiae, and Girk3-/- chondrocytes show enhanced responsiveness to the kappa opioid receptor ligand dynorphin (greater pCREB, cAMP, and GAG production; upregulation of Col2a1 and Sox9), along with reduced VEGF receptor expression and delayed vascularization of bone.","method":"Girk3-/- mouse skeletal phenotyping, primary chondrocyte cultures, in vitro micromass assays, KOR ligand stimulation, gene expression analysis, bone imaging","journal":"Bone","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO phenotype plus in vitro cellular assays with defined pathway readouts (cAMP, pCREB, gene expression), single lab, multiple methods","pmids":["35314385"],"is_preprint":false},{"year":2024,"finding":"Girk3 deletion in osteoblasts/osteocytes (via 2.3 kb-Col1a1-Cre) is sufficient to increase bone mass and bone strength in male mice; Girk3-/- bone marrow stromal cells are more proliferative and osteogenic, with altered Wnt pathway gene expression; Wnt/β-catenin inhibition prevents enhanced mineralization in Girk3-/- cells.","method":"Conditional KO (Col1a1-Cre), germline Girk3-/- mice, microCT, histomorphometry, in vitro BMSC and calvarial osteoblast cultures, Wnt inhibitor treatments","journal":"JBMR plus","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-type-specific KO with defined phenotype, in vitro mechanistic follow-up with pathway inhibitors, single lab","pmids":["39228688"],"is_preprint":false}],"current_model":"KCNJ9/GIRK3 (Kir3.3) is a pore-forming subunit of G-protein-gated inwardly rectifying K+ (GIRK) channels that co-assembles with GIRK1, GIRK2, or GIRK4 into heterotetrameric complexes activated by Gβγ; in neurons, GIRK3-containing channels mediate acute opioid and GABA-B receptor inhibition of locus ceruleus and VTA dopamine neurons, gate mesolimbic dopamine responses to ethanol, and are required for methamphetamine-induced plasticity of GABA-B/GIRK signaling; GIRK3 directly interacts with GABA-B receptors, NCAM, and TrkB through its C-terminal domain, with TrkB regulating its plasma membrane expression; in non-excitable chondrocytes and osteoblasts, GIRK3 controls endochondral ossification and bone mass accrual via GPCR (kappa opioid receptor) and Wnt signaling pathways."},"narrative":{"mechanistic_narrative":"KCNJ9/GIRK3 (Kir3.3) is a pore-forming subunit of G-protein-gated inwardly rectifying K+ (GIRK) channels that co-assembles with GIRK1 or GIRK2 into functional heteromultimeric channels gated by Gβγ, with GIRK2/GIRK3 channels showing markedly lower Gβγ sensitivity than GIRK1-containing channels [PMID:10341034, PMID:10956667]. In neurons, GIRK2/GIRK3-containing channels mediate the acute opioid-induced hyperpolarization of locus ceruleus neurons, accounting for the bulk of the opioid-sensitive K+ current [PMID:12040038], and GIRK3 sits in a shared pathway downstream of opioid, α2-adrenergic, and cannabinoid receptors that produces analgesia [PMID:18300945]. GIRK3 assembles into stable receptor-channel complexes with GABA-B receptors as GIRK1/GIRK3 heterotetramers, likely forming early in the secretory pathway [PMID:20846323], and its C-terminal intracellular domain directly binds NCAM and TrkB, the latter regulating GIRK3 plasma-membrane expression [PMID:20610389]. Through these channels GIRK3 shapes addiction-relevant circuitry: it gates the mesolimbic dopaminergic response to ethanol in the VTA [PMID:25964320], is required for methamphetamine-induced plasticity of GABA-B/GIRK signaling [PMID:26985023], and contributes to sedative-hypnotic withdrawal severity [PMID:19759313]. Beyond the nervous system, GIRK3 acts in non-excitable skeletal cells, restraining endochondral bone formation downstream of kappa-opioid receptor signaling in chondrocytes [PMID:35314385] and limiting bone mass in osteoblasts/osteocytes through modulation of Wnt/β-catenin signaling [PMID:39228688].","teleology":[{"year":1999,"claim":"Established that GIRK3 is not an orphan subunit but co-assembles with GIRK1 into functional Gβγ-gated K+ channels, defining its molecular identity as a GIRK channel subunit.","evidence":"Patch-clamp electrophysiology of GIRK1/GIRK3 channels in CHO cells","pmids":["10341034"],"confidence":"Medium","gaps":["Single in vitro reconstitution, no native-tissue confirmation in this study","Did not address other partner subunits or physiological context"]},{"year":2000,"claim":"Showed GIRK3 also partners with GIRK2 to form channels with distinct (lower) Gβγ sensitivity, revealing that subunit composition tunes channel gating properties.","evidence":"Patch-clamp, co-immunoprecipitation from transfected cells and native brain tissue","pmids":["10956667"],"confidence":"High","gaps":["Functional consequence of reduced Gβγ sensitivity in neurons not yet tested","Stoichiometry of native complexes not resolved"]},{"year":2002,"claim":"Demonstrated a defined neuronal function: GIRK2/GIRK3 channels mediate acute opioid hyperpolarization of locus ceruleus neurons, linking the subunit to GPCR-driven inhibition.","evidence":"Brain slice patch-clamp in Kir3.2, Kir3.3, and double-KO mice with pharmacology","pmids":["12040038"],"confidence":"High","gaps":["Relative contribution of GIRK3 alone (vs GIRK2) not isolated","Did not address GIRK3 role outside locus ceruleus"]},{"year":2003,"claim":"Revealed unusual axonal/presynaptic sorting of GIRK3 in hippocampal GABAergic interneurons, distinguishing its trafficking from somatodendritic Kir3 subunits.","evidence":"Immunocytochemistry and EM in primary cultures and tissue","pmids":["14664820"],"confidence":"Medium","gaps":["Sorting determinants and functional role of axonal GIRK3 not established","Single lab, descriptive localization only"]},{"year":2008,"claim":"Genetic KO placed GIRK3 in a convergent multi-receptor analgesic pathway and identified cis-acting strain variation in Kcnj9 expression, connecting the gene to pharmacogenetic differences.","evidence":"Kcnj9-KO hot-plate analgesia plus QTL/haplotype mapping in F2 mice","pmids":["18300945"],"confidence":"Medium","gaps":["Circuit/cell-type basis of attenuated analgesia not mapped","Causal cis-element not identified"]},{"year":2009,"claim":"Extended GIRK3's behavioral role to sedative-hypnotic and ethanol withdrawal, showing reduced expression attenuates withdrawal severity.","evidence":"Kcnj9-null mice in withdrawal behavioral assays across multiple drugs","pmids":["19759313"],"confidence":"Medium","gaps":["Underlying circuit and channel-level mechanism not defined","Single lab behavioral readout"]},{"year":2010,"claim":"Defined the protein interactome of GIRK3: stable assembly with GABA-B receptors as GIRK1/GIRK3 tetramers, and direct C-terminal binding to NCAM and TrkB with TrkB controlling surface expression.","evidence":"BRET, reciprocal co-IP, surface biotinylation, Xenopus oocyte electrophysiology, TrkB-KO mice","pmids":["20846323","20610389"],"confidence":"High","gaps":["Structural basis of C-terminal interactions not resolved","In vivo significance of NCAM/TrkB regulation in adult circuits not fully established"]},{"year":2016,"claim":"Linked GIRK3 to addiction circuitry: it gates VTA dopamine-neuron sensitivity to ethanol (with viral rescue) and is required for methamphetamine-induced plasticity of GABA-B/GIRK signaling.","evidence":"GIRK3-KO mice, VTA viral re-expression, microdialysis, slice electrophysiology, pharmacology, behavior","pmids":["25964320","26985023"],"confidence":"High","gaps":["Molecular link between GIRK3 subunit composition and ethanol excitation not fully mechanistic","Signaling intermediary for methamphetamine plasticity downstream of D1/D2 not identified"]},{"year":2024,"claim":"Established a non-neuronal role: GIRK3 restrains endochondral bone formation and bone mass via KOR signaling in chondrocytes and Wnt/β-catenin signaling in osteoblasts.","evidence":"Germline and Col1a1-Cre conditional Girk3 KO, microCT, histomorphometry, primary chondrocyte/BMSC cultures, KOR ligand and Wnt inhibitor treatments","pmids":["35314385","39228688"],"confidence":"Medium","gaps":["Whether GIRK3 acts as a K+ channel or scaffold in skeletal cells not resolved","Mechanism linking K+ flux to cAMP/CREB and Wnt outputs unknown"]},{"year":null,"claim":"How GIRK3 subunit incorporation mechanistically converts upstream GPCR signals into the diverse cell-type-specific outputs (neuronal excitability, dopamine sensitivity, bone formation) remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of GIRK3-containing channels or its interaction interfaces","Unclear whether skeletal phenotypes require channel conductance or scaffolding function","Channel-level basis of withdrawal and analgesia phenotypes undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,2]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,1]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[7,8]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[8]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[3,4]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[2,9,10]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[7,11,12]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[11,12]}],"complexes":["GIRK1/GIRK3 channel","GIRK2/GIRK3 channel","GABA-B receptor-GIRK1/GIRK3 complex"],"partners":["KCNJ3","KCNJ6","GABBR1","GABBR2","NCAM1","NTRK2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q92806","full_name":"G protein-activated inward rectifier potassium channel 3","aliases":["Inward rectifier K(+) channel Kir3.3","Potassium channel, inwardly rectifying subfamily J member 9"],"length_aa":393,"mass_kda":44.0,"function":"Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium, This receptor is controlled by G proteins. Unable to produce channel activity when expressed alone (PubMed:10659995). Forms a functional channel in association with KCNJ3/GIRK1 (By similarity)","subcellular_location":"Membrane","url":"https://www.uniprot.org/uniprotkb/Q92806/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KCNJ9","classification":"Not Classified","n_dependent_lines":137,"n_total_lines":1208,"dependency_fraction":0.11341059602649006},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KCNJ9","total_profiled":1310},"omim":[{"mim_id":"600932","title":"POTASSIUM INWARDLY-RECTIFYING CHANNEL, SUBFAMILY J, MEMBER 9; KCNJ9","url":"https://www.omim.org/entry/600932"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":69.4}],"url":"https://www.proteinatlas.org/search/KCNJ9"},"hgnc":{"alias_symbol":["Kir3.3","GIRK3"],"prev_symbol":[]},"alphafold":{"accession":"Q92806","domains":[{"cath_id":"1.10.287.70","chopping":"40-162","consensus_level":"high","plddt":93.5882,"start":40,"end":162},{"cath_id":"2.60.40.1400","chopping":"166-335","consensus_level":"high","plddt":94.2628,"start":166,"end":335}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92806","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q92806-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q92806-F1-predicted_aligned_error_v6.png","plddt_mean":85.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KCNJ9","jax_strain_url":"https://www.jax.org/strain/search?query=KCNJ9"},"sequence":{"accession":"Q92806","fasta_url":"https://rest.uniprot.org/uniprotkb/Q92806.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q92806/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92806"}},"corpus_meta":[{"pmid":"12040038","id":"PMC_12040038","title":"G-protein-gated potassium channels containing Kir3.2 and Kir3.3 subunits mediate the acute inhibitory effects of opioids on locus ceruleus neurons.","date":"2002","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12040038","citation_count":163,"is_preprint":false},{"pmid":"10956667","id":"PMC_10956667","title":"Functional and biochemical evidence for G-protein-gated inwardly rectifying K+ (GIRK) channels composed of GIRK2 and GIRK3.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10956667","citation_count":88,"is_preprint":false},{"pmid":"10341034","id":"PMC_10341034","title":"Functional expression and characterization of G-protein-gated inwardly rectifying K+ channels containing GIRK3.","date":"1999","source":"The Journal of membrane biology","url":"https://pubmed.ncbi.nlm.nih.gov/10341034","citation_count":50,"is_preprint":false},{"pmid":"25964320","id":"PMC_25964320","title":"GIRK3 gates activation of the mesolimbic dopaminergic pathway by ethanol.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25964320","citation_count":49,"is_preprint":false},{"pmid":"19759313","id":"PMC_19759313","title":"Mapping a barbiturate withdrawal locus to a 0.44 Mb interval and analysis of a novel null mutant identify a role for Kcnj9 (GIRK3) in withdrawal from pentobarbital, zolpidem, and ethanol.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19759313","citation_count":49,"is_preprint":false},{"pmid":"20846323","id":"PMC_20846323","title":"Evidence for oligomerization between GABAB receptors and GIRK channels containing the GIRK1 and GIRK3 subunits.","date":"2010","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20846323","citation_count":48,"is_preprint":false},{"pmid":"18300945","id":"PMC_18300945","title":"Quantitative trait locus and computational mapping identifies Kcnj9 (GIRK3) as a candidate gene affecting analgesia from multiple drug classes.","date":"2008","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/18300945","citation_count":46,"is_preprint":false},{"pmid":"26985023","id":"PMC_26985023","title":"A Role for the GIRK3 Subunit in Methamphetamine-Induced Attenuation of GABAB Receptor-Activated GIRK Currents in VTA Dopamine Neurons.","date":"2016","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26985023","citation_count":32,"is_preprint":false},{"pmid":"14664820","id":"PMC_14664820","title":"Axonal sorting of Kir3.3 defines a GABA-containing neuron in the CA3 region of rodent hippocampus.","date":"2003","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/14664820","citation_count":24,"is_preprint":false},{"pmid":"11350189","id":"PMC_11350189","title":"Analysis of linkage disequilibrium between polymorphisms in the KCNJ9 gene with type 2 diabetes mellitus in Pima Indians.","date":"2001","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/11350189","citation_count":20,"is_preprint":false},{"pmid":"20610389","id":"PMC_20610389","title":"Functional consequences of the interactions among the neural cell adhesion molecule NCAM, the receptor tyrosine kinase TrkB, and the inwardly rectifying K+ channel KIR3.3.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20610389","citation_count":20,"is_preprint":false},{"pmid":"10913335","id":"PMC_10913335","title":"Genomic structure and expression of human KCNJ9 (Kir3.3/GIRK3).","date":"2000","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10913335","citation_count":18,"is_preprint":false},{"pmid":"35314385","id":"PMC_35314385","title":"GIRK3 deletion facilitates kappa opioid signaling in chondrocytes, delays vascularization and promotes bone lengthening in mice.","date":"2022","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/35314385","citation_count":8,"is_preprint":false},{"pmid":"39228688","id":"PMC_39228688","title":"Girk3 deletion increases osteoblast maturation and bone mass accrual in adult male mice.","date":"2024","source":"JBMR plus","url":"https://pubmed.ncbi.nlm.nih.gov/39228688","citation_count":2,"is_preprint":false},{"pmid":"18755244","id":"PMC_18755244","title":"Expression of Kir3.3 potassium channel subunits in supraependymal axons.","date":"2008","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/18755244","citation_count":2,"is_preprint":false},{"pmid":"39801366","id":"PMC_39801366","title":"Atp1a2 and Kcnj9 Are Candidate Genes Underlying Sensitivity to Oxycodone-Induced Locomotor Activation and Withdrawal-Induced Anxiety-Like Behaviors in C57BL/6 Substrains.","date":"2025","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/39801366","citation_count":1,"is_preprint":false},{"pmid":"38798314","id":"PMC_38798314","title":"Atp1a2 and Kcnj9 are candidate genes underlying sensitivity to oxycodone-induced locomotor activation and withdrawal-induced anxiety-like behaviors in C57BL/6 substrains.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38798314","citation_count":0,"is_preprint":false},{"pmid":"41084512","id":"PMC_41084512","title":"Global but not myeloid lineage-directed Girk3 deletion increases bone mass in female mice.","date":"2025","source":"JBMR plus","url":"https://pubmed.ncbi.nlm.nih.gov/41084512","citation_count":0,"is_preprint":false},{"pmid":"41490595","id":"PMC_41490595","title":"The circ-GLG1/miR-346/KCNJ9 axis drives malignant progression of bladder cancer by modulating KCNJ9 expression.","date":"2026","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/41490595","citation_count":0,"is_preprint":false},{"pmid":"36833293","id":"PMC_36833293","title":"De Novo Variant in the KCNJ9 Gene as a Possible Cause of Neonatal Seizures.","date":"2023","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/36833293","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":12888,"output_tokens":3626,"usd":0.046527,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":11210,"output_tokens":3626,"usd":0.07335,"stage2_stop_reason":"end_turn"},"total_usd":0.119877,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"GIRK3 (Kir3.3) co-assembles with GIRK1 to form functional heteromultimeric G-protein-gated inwardly rectifying K+ channels in CHO cells; the GIRK1/GIRK3 channel has nearly identical single-channel conductance, kinetics, and Gβγ sensitivity compared to GIRK1/GIRK2 and GIRK1/GIRK4 channels.\",\n      \"method\": \"Patch-clamp electrophysiology and CHO cell expression system\",\n      \"journal\": \"The Journal of membrane biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro functional reconstitution with single-channel characterization, single lab, single study\",\n      \"pmids\": [\"10341034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"GIRK2 and GIRK3 co-assemble to form functional heteromultimeric GIRK channels in CHO-K1 cells; these GIRK2/GIRK3 channels have approximately 5-fold lower sensitivity to activation by Gβγ compared to GIRK1-containing channels. GIRK2/GIRK3 complexes were immunoprecipitated from transfected cells and purified from native brain tissue.\",\n      \"method\": \"Patch-clamp electrophysiology, co-immunoprecipitation, co-transfection in CHO-K1 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — functional reconstitution with electrophysiology plus reciprocal co-IP from both transfected cells and native brain tissue, single lab but two orthogonal methods\",\n      \"pmids\": [\"10956667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"G-protein-gated K+ channels containing Kir3.2 (GIRK2) and Kir3.3 (GIRK3) subunits mediate acute opioid ([Met]5enkephalin)-induced hyperpolarization of locus ceruleus neurons; Kir3.2/3.3 double knockout abolished ~80% of the opioid-sensitive current, and residual current was blocked by Ba2+/Cs+. The cAMP-dependent cation conductance does not contribute significantly to acute opioid inhibition.\",\n      \"method\": \"Brain slice patch-clamp electrophysiology in Kir3.2 KO, Kir3.3 KO, and Kir3.2/3.3 double KO mice\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO with defined cellular phenotype and pharmacological validation, replicated across multiple genotypes\",\n      \"pmids\": [\"12040038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Kir3.3 (GIRK3) protein is specifically sorted to axons in a population of large GABAergic interneurons in the CA3 region of rodent hippocampus, where it colocalizes with the vesicular GABA transporter in large synaptic terminals; this axonal sorting is distinct from the somatodendritic localization of most Kir3 subunits.\",\n      \"method\": \"Immunocytochemistry, primary hippocampal subarea cultures, light and electron microscopy\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct localization by immunocytochemistry and EM in primary cultures and brain tissue, single lab, single study\",\n      \"pmids\": [\"14664820\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Kir3.3 (GIRK3) protein is expressed in serotonergic supraependymal axons of dorsal raphe neurons at the light and electron microscopic level, with no other Kir3 subfamily members or KATP subunits detectable in these axons, suggesting a role in excitability autoregulation of these fibers.\",\n      \"method\": \"Immunocytochemistry (light and electron microscopy)\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — localization by immunocytochemistry alone, no functional consequence established, single lab\",\n      \"pmids\": [\"18755244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Kcnj9 (GIRK3) knockout mice have attenuated analgesic responses to opioid (morphine), α2-adrenergic (clonidine), and cannabinoid (WIN55,212-2) drugs, placing GIRK3 in the pathway of multi-drug analgesic signaling; differential expression of Kcnj9 in the periaqueductal gray between 129P3 and C57BL/6 strains is driven by cis-acting genetic elements.\",\n      \"method\": \"QTL mapping in F2 mice, in silico haplotype analysis, Kcnj9 knockout phenotyping with hot-plate analgesia assay\",\n      \"journal\": \"Pharmacogenetics and genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO with defined phenotypic readout plus QTL/computational mapping, two orthogonal approaches, single lab\",\n      \"pmids\": [\"18300945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Kcnj9 (GIRK3) null mutant mice exhibit significantly less severe withdrawal from pentobarbital, zolpidem, and ethanol compared to wild-type littermates, demonstrating a role for GIRK3 in sedative-hypnotic withdrawal; reduced Kcnj9 expression is associated with attenuated withdrawal severity.\",\n      \"method\": \"Generation of Kcnj9-null mice, sedative-hypnotic withdrawal behavioral assays\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined behavioral phenotype across multiple drugs, single lab\",\n      \"pmids\": [\"19759313\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"GABA-B receptors form stable protein complexes with GIRK channels containing the GIRK1 and GIRK3 subunits (GIRK1/GIRK3 heterotetramers); BRET measurements in living cells showed direct interaction, and co-IP confirmed complexes in HEK-293 cells and in vivo in cerebellar granule cells. These receptor-channel complexes are likely assembled shortly after biosynthesis in the ER/Golgi.\",\n      \"method\": \"Bioluminescence resonance energy transfer (BRET), co-immunoprecipitation, confocal and electron microscopy in HEK-293 cells and native cerebellar tissue\",\n      \"journal\": \"The European journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP plus BRET in living cells plus in vivo tissue confirmation, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"20846323\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Kir3.3 (GIRK3) directly binds to NCAM and TrkB via its C-terminal intracellular domain; TrkB co-expression increases Kir3.1/3.3-mediated K+ currents in Xenopus oocytes, while NCAM co-expression reduces this enhancement; TrkB regulates cell surface expression of Kir3.3 (but not Kir3.2), and TrkB-deficient mice have reduced Kir3.3 at the plasma membrane; premature expression of Kir3.1/3.3 in hippocampal neurons reduces NCAM-induced neurite outgrowth.\",\n      \"method\": \"Co-immunoprecipitation, surface biotinylation, Xenopus oocyte electrophysiology, immunocytochemistry, TrkB-KO mouse analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (Co-IP, surface biotinylation, electrophysiology, KO mice), direct binding sites identified, single lab\",\n      \"pmids\": [\"20610389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GIRK3 expression in the ventral tegmental area (VTA) gates the mesolimbic dopaminergic pathway response to ethanol; GIRK3 KO mice show blunted ethanol-induced excitation of VTA neurons and reduced dopamine release in the nucleus accumbens; viral re-expression of GIRK3 in VTA rescued the KO phenotype and reduced ethanol binge drinking, demonstrating that VTA GIRK channel subunit composition determines DA neuron sensitivity to ethanol.\",\n      \"method\": \"GIRK3 KO mice, viral vector-mediated re-expression in VTA, in vivo microdialysis (dopamine), brain slice electrophysiology, voluntary ethanol consumption assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO phenotype with viral rescue, multiple orthogonal readouts (electrophysiology, microdialysis, behavior), single lab but multiple methods\",\n      \"pmids\": [\"25964320\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The GIRK3 subunit is required for methamphetamine-induced attenuation of GABA-B receptor-activated GIRK currents in VTA dopamine neurons; this methamphetamine-dependent plasticity requires both D1R-like and D2R-like receptor activation and is independent of GABA-B R2 subunit dephosphorylation.\",\n      \"method\": \"Brain slice patch-clamp electrophysiology in GIRK3 KO and wild-type mice, pharmacological receptor antagonism, repeated methamphetamine treatment paradigm\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined cellular phenotype, pharmacological dissection of upstream signaling requirements, single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"26985023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GIRK3 controls endochondral bone formation in non-excitable chondrocytes; Girk3-/- mice have longer femurs and tibiae, and Girk3-/- chondrocytes show enhanced responsiveness to the kappa opioid receptor ligand dynorphin (greater pCREB, cAMP, and GAG production; upregulation of Col2a1 and Sox9), along with reduced VEGF receptor expression and delayed vascularization of bone.\",\n      \"method\": \"Girk3-/- mouse skeletal phenotyping, primary chondrocyte cultures, in vitro micromass assays, KOR ligand stimulation, gene expression analysis, bone imaging\",\n      \"journal\": \"Bone\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO phenotype plus in vitro cellular assays with defined pathway readouts (cAMP, pCREB, gene expression), single lab, multiple methods\",\n      \"pmids\": [\"35314385\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Girk3 deletion in osteoblasts/osteocytes (via 2.3 kb-Col1a1-Cre) is sufficient to increase bone mass and bone strength in male mice; Girk3-/- bone marrow stromal cells are more proliferative and osteogenic, with altered Wnt pathway gene expression; Wnt/β-catenin inhibition prevents enhanced mineralization in Girk3-/- cells.\",\n      \"method\": \"Conditional KO (Col1a1-Cre), germline Girk3-/- mice, microCT, histomorphometry, in vitro BMSC and calvarial osteoblast cultures, Wnt inhibitor treatments\",\n      \"journal\": \"JBMR plus\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific KO with defined phenotype, in vitro mechanistic follow-up with pathway inhibitors, single lab\",\n      \"pmids\": [\"39228688\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KCNJ9/GIRK3 (Kir3.3) is a pore-forming subunit of G-protein-gated inwardly rectifying K+ (GIRK) channels that co-assembles with GIRK1, GIRK2, or GIRK4 into heterotetrameric complexes activated by Gβγ; in neurons, GIRK3-containing channels mediate acute opioid and GABA-B receptor inhibition of locus ceruleus and VTA dopamine neurons, gate mesolimbic dopamine responses to ethanol, and are required for methamphetamine-induced plasticity of GABA-B/GIRK signaling; GIRK3 directly interacts with GABA-B receptors, NCAM, and TrkB through its C-terminal domain, with TrkB regulating its plasma membrane expression; in non-excitable chondrocytes and osteoblasts, GIRK3 controls endochondral ossification and bone mass accrual via GPCR (kappa opioid receptor) and Wnt signaling pathways.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"KCNJ9/GIRK3 (Kir3.3) is a pore-forming subunit of G-protein-gated inwardly rectifying K+ (GIRK) channels that co-assembles with GIRK1 or GIRK2 into functional heteromultimeric channels gated by Gβγ, with GIRK2/GIRK3 channels showing markedly lower Gβγ sensitivity than GIRK1-containing channels [#0, #1]. In neurons, GIRK2/GIRK3-containing channels mediate the acute opioid-induced hyperpolarization of locus ceruleus neurons, accounting for the bulk of the opioid-sensitive K+ current [#2], and GIRK3 sits in a shared pathway downstream of opioid, α2-adrenergic, and cannabinoid receptors that produces analgesia [#5]. GIRK3 assembles into stable receptor-channel complexes with GABA-B receptors as GIRK1/GIRK3 heterotetramers, likely forming early in the secretory pathway [#7], and its C-terminal intracellular domain directly binds NCAM and TrkB, the latter regulating GIRK3 plasma-membrane expression [#8]. Through these channels GIRK3 shapes addiction-relevant circuitry: it gates the mesolimbic dopaminergic response to ethanol in the VTA [#9], is required for methamphetamine-induced plasticity of GABA-B/GIRK signaling [#10], and contributes to sedative-hypnotic withdrawal severity [#6]. Beyond the nervous system, GIRK3 acts in non-excitable skeletal cells, restraining endochondral bone formation downstream of kappa-opioid receptor signaling in chondrocytes [#11] and limiting bone mass in osteoblasts/osteocytes through modulation of Wnt/β-catenin signaling [#12].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established that GIRK3 is not an orphan subunit but co-assembles with GIRK1 into functional Gβγ-gated K+ channels, defining its molecular identity as a GIRK channel subunit.\",\n      \"evidence\": \"Patch-clamp electrophysiology of GIRK1/GIRK3 channels in CHO cells\",\n      \"pmids\": [\"10341034\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Single in vitro reconstitution, no native-tissue confirmation in this study\",\n        \"Did not address other partner subunits or physiological context\"\n      ]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Showed GIRK3 also partners with GIRK2 to form channels with distinct (lower) Gβγ sensitivity, revealing that subunit composition tunes channel gating properties.\",\n      \"evidence\": \"Patch-clamp, co-immunoprecipitation from transfected cells and native brain tissue\",\n      \"pmids\": [\"10956667\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Functional consequence of reduced Gβγ sensitivity in neurons not yet tested\",\n        \"Stoichiometry of native complexes not resolved\"\n      ]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrated a defined neuronal function: GIRK2/GIRK3 channels mediate acute opioid hyperpolarization of locus ceruleus neurons, linking the subunit to GPCR-driven inhibition.\",\n      \"evidence\": \"Brain slice patch-clamp in Kir3.2, Kir3.3, and double-KO mice with pharmacology\",\n      \"pmids\": [\"12040038\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Relative contribution of GIRK3 alone (vs GIRK2) not isolated\",\n        \"Did not address GIRK3 role outside locus ceruleus\"\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Revealed unusual axonal/presynaptic sorting of GIRK3 in hippocampal GABAergic interneurons, distinguishing its trafficking from somatodendritic Kir3 subunits.\",\n      \"evidence\": \"Immunocytochemistry and EM in primary cultures and tissue\",\n      \"pmids\": [\"14664820\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Sorting determinants and functional role of axonal GIRK3 not established\",\n        \"Single lab, descriptive localization only\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Genetic KO placed GIRK3 in a convergent multi-receptor analgesic pathway and identified cis-acting strain variation in Kcnj9 expression, connecting the gene to pharmacogenetic differences.\",\n      \"evidence\": \"Kcnj9-KO hot-plate analgesia plus QTL/haplotype mapping in F2 mice\",\n      \"pmids\": [\"18300945\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Circuit/cell-type basis of attenuated analgesia not mapped\",\n        \"Causal cis-element not identified\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Extended GIRK3's behavioral role to sedative-hypnotic and ethanol withdrawal, showing reduced expression attenuates withdrawal severity.\",\n      \"evidence\": \"Kcnj9-null mice in withdrawal behavioral assays across multiple drugs\",\n      \"pmids\": [\"19759313\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Underlying circuit and channel-level mechanism not defined\",\n        \"Single lab behavioral readout\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined the protein interactome of GIRK3: stable assembly with GABA-B receptors as GIRK1/GIRK3 tetramers, and direct C-terminal binding to NCAM and TrkB with TrkB controlling surface expression.\",\n      \"evidence\": \"BRET, reciprocal co-IP, surface biotinylation, Xenopus oocyte electrophysiology, TrkB-KO mice\",\n      \"pmids\": [\"20846323\", \"20610389\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Structural basis of C-terminal interactions not resolved\",\n        \"In vivo significance of NCAM/TrkB regulation in adult circuits not fully established\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Linked GIRK3 to addiction circuitry: it gates VTA dopamine-neuron sensitivity to ethanol (with viral rescue) and is required for methamphetamine-induced plasticity of GABA-B/GIRK signaling.\",\n      \"evidence\": \"GIRK3-KO mice, VTA viral re-expression, microdialysis, slice electrophysiology, pharmacology, behavior\",\n      \"pmids\": [\"25964320\", \"26985023\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Molecular link between GIRK3 subunit composition and ethanol excitation not fully mechanistic\",\n        \"Signaling intermediary for methamphetamine plasticity downstream of D1/D2 not identified\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Established a non-neuronal role: GIRK3 restrains endochondral bone formation and bone mass via KOR signaling in chondrocytes and Wnt/β-catenin signaling in osteoblasts.\",\n      \"evidence\": \"Germline and Col1a1-Cre conditional Girk3 KO, microCT, histomorphometry, primary chondrocyte/BMSC cultures, KOR ligand and Wnt inhibitor treatments\",\n      \"pmids\": [\"35314385\", \"39228688\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Whether GIRK3 acts as a K+ channel or scaffold in skeletal cells not resolved\",\n        \"Mechanism linking K+ flux to cAMP/CREB and Wnt outputs unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How GIRK3 subunit incorporation mechanistically converts upstream GPCR signals into the diverse cell-type-specific outputs (neuronal excitability, dopamine sensitivity, bone formation) remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"No structural model of GIRK3-containing channels or its interaction interfaces\",\n        \"Unclear whether skeletal phenotypes require channel conductance or scaffolding function\",\n        \"Channel-level basis of withdrawal and analgesia phenotypes undefined\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [7, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [3, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [2, 9, 10]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [7, 11, 12]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [11, 12]}\n    ],\n    \"complexes\": [\n      \"GIRK1/GIRK3 channel\",\n      \"GIRK2/GIRK3 channel\",\n      \"GABA-B receptor-GIRK1/GIRK3 complex\"\n    ],\n    \"partners\": [\n      \"KCNJ3\",\n      \"KCNJ6\",\n      \"GABBR1\",\n      \"GABBR2\",\n      \"NCAM1\",\n      \"NTRK2\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}